Glucotrack (GCTK) Research & Development (2010 - 2025)
Glucotrack (GCTK) posted Research & Development of $1.6 million for Q4 2025, down 48.59% on a QoQ basis from $3.2 million in Q3 2025, and down 4.24% year-over-year from $1.7 million in Q4 2024.
Glucotrack (GCTK) Research & Development (2010 - 2025) Analysis & Trends
Glucotrack's Research & Development history runs 15 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- Quarterly Research & Development fell 4.24% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (down 15.04% YoY) and the FY2025 annual result came in at $9.8 million, up 3.31% from the prior year.
- Research & Development was $1.6 million for Q4 2025 at Glucotrack, down from $3.2 million in the prior quarter.
- Across five years, Research & Development topped out at $3.6 million in Q2 2024 and bottomed at -$2.8 million in Q4 2023.
- A 5-year average of $1.0 million and a median of $615500.0 in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 20033.33% — and 2023, when it sank 568.71%.
- Glucotrack's Research & Development stood at $3000.0 in 2021, then jumped by 20033.33% to $604000.0 in 2022, then sank by 568.71% to -$2.8 million in 2023, then soared by 160.01% to $1.7 million in 2024, then fell by 4.24% to $1.6 million in 2025.
- Business Quant data shows GCTK's Research & Development at $1.6 million in Q4 2025, $3.2 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | -2.83 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 113,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 309,000.00 |